Protalix BioTherapeutics
PLX
#8704
Rank
ยฃ0.13 B
Marketcap
ยฃ1.65
Share price
0.92%
Change (1 day)
-16.29%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): ยฃ0.01352

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is ยฃ0.01503. In 2024 the company made an earnings per share (EPS) of ยฃ0.03005 a decrease over its 2023 EPS that were of ยฃ0.09016.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ0.01352-55%
2024ยฃ0.03005-66.67%
2023ยฃ0.09016-138.71%
2022-ยฃ0.23-50%
2021-ยฃ0.47181.82%
2020-ยฃ0.17-82.11%
2019-ยฃ0.92-31.67%
2018-ยฃ1.35-72.31%
2017-ยฃ4.88124.14%
2016-ยฃ2.18-147.54%
2015ยฃ4.58-290.62%
2014-ยฃ2.406.67%
2013-ยฃ2.25130.77%
2012-ยฃ0.98-69.77%
2011-ยฃ3.2319.44%
2010-ยฃ2.70-12.2%
2009-ยฃ3.0836.67%
2008-ยฃ2.25-37.5%
2007-ยฃ3.6150%
2006-ยฃ2.403.23%
2005-ยฃ2.33138.46%
2004-ยฃ0.98-74%
2003-ยฃ3.76-0%
2002-ยฃ3.76-50%
2001-ยฃ7.51233.33%
2000-ยฃ2.25-84.21%
1999-ยฃ14.28-24%
1998-ยฃ18.78-600%
1997ยฃ3.76-16.67%
1996ยฃ4.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ1.02 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ3.62 24,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-ยฃ0.08264-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.93 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel